Prevalence and prognostic implications of non-sustained ventricular tachycardia in ST-segment elevation myocardial infarction after revascularization with either fibrinolysis or primary angioplasty

European Heart Journal

Volumn 28, Issue 4, 2007, Pages 407-414

  Høfsten, Dan Eik ^a   Wachtell, Kristian ^c   Lund, Birgit ^b   Mølgaard, Henning ^b   Egstrup, Kenneth ^a  

^a SVENDBORG HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

Angioplasty; Arrhythmia; Electrocardiography; Myocardial infarction; Risk factors

Indexed keywords

FIBRINOLYTIC AGENT;

ADULT; AGED; ANGIOPLASTY; ARTICLE; CAUSE OF DEATH; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HAZARD RATIO; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZATION; RISK FACTOR; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANGIOPLASTY; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; SURVIVAL ANALYSIS; TACHYCARDIA, VENTRICULAR; THROMBOLYTIC THERAPY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34548251001     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehl476     Document Type: Article

References (20)

1. Moss AJ. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309:331-336.
2. Hohnloser SH, Gersh BJ. Changing late prognosis of acute myocardial infarction: impact on management of ventricular arrhythmias in the era of reperfusion and the implantable cardioverter-defibrillator. Circulation 2003;107:941-946.
3. Maggioni AP, Zuanetti G, Franzosi MG, Rovelli F, Santoro E, Staszewsky L, Tavazzi L, Tognoni G. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era: Gissi-2 results. Circulation 1993;87:312-322.
4. Hohnloser SH, Klingenheben T, Zabel M, Schopperl M, Mauss O. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era. J Am Coll Cardiol 1999;33:1895-1902.
5. Andresen D, Steinbeck G, Bruggemann T, Muller D, Haberl R, Behrens S, Hoffmann E, Wegscheider K, Dissmann R, Ehlers HC. Risk stratification following myocardial infarction in the thrombolytic era: a two-step strategy using non-invasive and invasive methods. J Am Coll Cardiol 1999;33:131- 138.
6. Cheema AN, Sheu K, Parker M, Kadish AH, Goldberger JJ. Non-sustained ventricular tachycardia in the setting of acute myocardial infarction: tachycardia characteristics and their prognostic implications. Circulation 1998;98:2030-2036.
7. Huikuri HV, Tapanainen JM, Lindgren K, Raatikainen P, Makikallio TH, Airaksinen KEJ, Myerburg RJ. Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J Am Coll Cardiol 2003;42:652-658.
8. Vaage-Nilsen M, Rasmussen V, Hansen JF, Hagerup L, Sorensen MB, Pedersen-Bjergaard O, Mellemgaard K, Hollander NH, Nielsen I, Sigurd BM. Prognostic implications of ventricular ectopy one week, one month, and sixteen months after an acute myocardial infarction. Clin Cardiol 1998;21:905-911.
9. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1940.
10. Makikallio TH, Barthel P, Schneider R, Bauer A, Tapanainen JM, Tulppo MP, Schmidt G, Huikuri HV. Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era. Eur Heart J 2005;26:762-769.
11. Dalby M, Bouzamondo A, Lechat P, Montalescot G. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis. Circulation 2003;108:1809-1814.
12. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
13. Schwab JO, Schmitt H, Coch M, Bernhoeft F, Waas W, Raedle-Hurst T, Tillmanns HH, Waldecker B. Results and significance of holter monitoring after direct percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 2001;87:466-469.
14. Andersen HR, Nielsen TT, Vesterlund T, Grande P, Abildgaard U, Thayssen P, Pedersen F, Mortensen LS. Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the DANish trial in Acute Myocardial Infarction-2 (DANAMI-2). Am Heart J 2003;146:234-241.
15. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, Abildgaard U, Pedersen F, Madsen JK, Grande P, Villadsen AB, Krusell LR, Haghfelt T, Lomholt P, Husted SE, Vigholt E, Kjaergard HK, Mortensen LS. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003;349:733-742.
16. Bigger JT, Weld FM, Rolnitzky LM. Prevalence, characteristics and significance of ventricular tachycardia (3 or more complexes) detected with ambulatory electrocardiographic recording in the late hospital phase of acute myocardial infarction. Am J Cardiol 1981;48:815-823.
17. Gislason GH, Gadsboll N, Quinones MA, Kober L, Seibaek M, Burchardt H, Torp-Pedersen C. The reliability of echocardiographic left ventricular wall motion index to identify high-risk patients for multicenter studies. Echocardiography 2006;23:1-6.
18. Kober L, Torp-Pedersen C, Elming H, Burchardt H. Use of left ventricular ejection fraction or wall-motion score index in predicting arrhythmic death in patients following an acute myocardial infarction. The TRACE Study Group. Pacing Clin Electrophysiol 1997;20:2553-2559.
19. The TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial. N Engl J Med 1985;312:932-936.
20. Braunwald E, Domanski MJ, Fowler SE, Geller NL, Gersh BJ, Hsia J, Pfeffer MA, Rice MM, Rosenberg YD, Rouleau JL. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med 2004;351:2058- 2068.